SCHEMBL4771389

SCHEMBL4771389

O=C(O)C1CCCN1C(I)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
KDM4E B2RXH2 1/20 0.43
ITGB3 P05106 1/20 0.41
ITGB1 P05556 1/20 0.41
ITGAV P06756 1/20 0.41
ITGA5 P08648 1/20 0.41
ITGA4 P13612 1/20 0.41
ACE P12821 2/20 0.40
AGTR2 P50052 5/20 0.39
CYP1A2 P05177 1/20 0.39
LTA4H P09960 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4848261 0.88 KMT2A (0.43) ALDH1A1SMN1; SMN2KDM4EACE
SCHEMBL2032193 0.84 ALDH1A1 (0.48) ALDH1A1SMN1; SMN2KDM4EITGB3ITGB1
SCHEMBL1818486 0.84 ALDH1A1 (0.48) ALDH1A1SMN1; SMN2KDM4EITGB3ITGB1
SCHEMBL7959886 0.81 KDM4E (0.47) ALDH1A1SMN1; SMN2KDM4EITGB3ITGB1
SCHEMBL7973454 0.81 KDM4E (0.47) ALDH1A1SMN1; SMN2KDM4EITGB3ITGB1
SCHEMBL7973302 0.81 KDM4E (0.47) ALDH1A1SMN1; SMN2KDM4EITGB3ITGB1
SCHEMBL7976128 0.81 KDM4E (0.47) ALDH1A1SMN1; SMN2KDM4EITGB3ITGB1
SCHEMBL28860925 0.81 KDM4E (0.47) ALDH1A1SMN1; SMN2KDM4EITGB3ITGB1
SCHEMBL7973306 0.81 KDM4E (0.47) ALDH1A1SMN1; SMN2KDM4EITGB3ITGB1
SCHEMBL7959881 0.81 KDM4E (0.47) ALDH1A1SMN1; SMN2KDM4EITGB3ITGB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1957058-A1 COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS AND MICROBIAL DISEASES SCHERING CORPORATION (US) 2008-08-20 EP disclosed
WO-2007064749-A1 COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS AND MICROBIAL DISEASES SCHERING CORPORATION (US) 2007-06-07 WO disclosed